Literature DB >> 14734687

Noninvasive measurement of gastric accommodation by means of pertechnetate SPECT: limiting radiation dose without losing image quality.

Roelof J Bennink1, Bram D van den Elzen, Sjoerd D Kuiken, Guy E Boeckxstaens.   

Abstract

UNLABELLED: The gastric accommodation response to a meal is impaired in conditions such as functional dyspepsia. At present, a barostat study is the gold standard to assess fundic relaxation in response to a meal. However, this method is invasive and possibly induces artifacts as a result of positive intraluminal balloon pressure. A noninvasive scintigraphic test has been developed to measure gastric accommodation in humans. The aim of this study was to refine this method, increasing the imaging time span and limiting the radiation dose applied without losing image quality, so that repeated measurements within 1 subject are possible without increasing radiation risk.
METHODS: Thirteen healthy volunteers without gastrointestinal symptoms were recruited from a student population. Each volunteer had previously undergone a barostat study. After an overnight fast, volunteers were scanned twice on separate days after intravenous injection of 200 MBq (99m)Tc-pertechnetate. On 1 occasion, volunteers were pretreated with a proton pump inhibitor. Thirty minutes after injection, sequential, 7-min SPECT scans (72 views, 10 s/view, 128 matrix) were acquired on a dual-head gamma-camera system before and up to 2 h after ingestion of a test meal. After reconstruction (filtered backprojection, ramp-Butterworth filter; order, 10; cutoff, 0.45 Nyquist), fundus volume was calculated semiautomatically by means of a threshold voxel volume tool.
RESULTS: Limiting injection dose from 370-740 MBq to 200 MBq (99m)Tc-pertechnetate resulted in good-quality images, with high target-to-background ratio up to 150 min after injection. This represents a significant dose reduction, from 4.6-9.3 to 2.5 mSv. There was no significant difference between SPECT fundic volumes or accommodation response with or without proton pump inhibitor pretreatment. Volume kinetics were similar to those with barostat studies, but gastric volumes were inferior.
CONCLUSION: Refining the methodology yields an improved noninvasive test for the assessment of gastric accommodation without unnecessarily increasing radiation burden. This technique enables repeated and serial measurement of gastric accommodation to a test meal, a process that is potentially useful for characterization and follow-up of dyspeptic patients with and without drug intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734687

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  Fundic accommodation assessed by SPECT scanning: comparison with the gastric barostat.

Authors:  B D J van den Elzen; R J Bennink; R E Wieringa; G N J Tytgat; G E E Boeckxstaens
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

2.  From ischochymia to gastroparesis: proposed mechanisms and preferred management of dyspepsia over the centuries.

Authors:  Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2014-04-09       Impact factor: 3.199

3.  The Reproducibility of Tc-Pertechnetate Single Photon Emission Computed Tomography (SPECT) for Measurement of Gastric Accommodation in Healthy Humans: Evaluation of the Test Results Performed at the Same Time and Different Time of the Day.

Authors:  Pataramon Vasavid; Tawatchai Chaiwatanarata; Sutep Gonlachanvit
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

4.  Itopride for gastric volume, gastric emptying and drinking capacity in functional dyspepsia.

Authors:  Shahab Abid; Wasim Jafri; Maseeh Uz Zaman; Rakhshanda Bilal; Safia Awan; Aamir Abbas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06

5.  Lipomics: A Potential Carrier for the Intravenous Delivery of Lipophilic and Hydrophilic Drugs.

Authors:  David Ramírez-Hernández; Carlos Juárez-Osornio; Vanessa Izquierdo-Sánchez; Pavel A Figueroa-Rodríguez; Jorge Organista-Nava; Yazmín Gómez-Gómez; Luis Alberto Medina
Journal:  Pharmaceutics       Date:  2022-08-08       Impact factor: 6.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.